Background: A high burden of ventricular premature depolarizations (VPDs) has been associated with potentially reversible left ventricular (LV) dysfunction, termed as VPD-induced cardiomyopathy (CMP). However, many patients maintain normal LV function despite a high VPD burden. The purpose of this study was to identify CMP by right ventricle apex (RVa) pacing method in patients with high VPD burden.
INTRODUCTION
In the absence of overt structural heart disease, frequent ventricular premature depolarizations (VPDs) have been considered a benign condition. 1 However, some patients with frequent VPDs may develop potentially reversible ventricular dysfunction, termed as VPD-induced cardiomyopathy (CMP). 2, 3 Much of the pathophysiology underlying the development of VPD-induced CMP remains incompletely understood. Several recent studies have demonstrated that a high (>10-20%) burden of VPDs is correlated with the presence of left ventricular (LV) dysfunction. 4 On the other hand, many patients with a high VPD burden maintain ventricular function over long-term followup. Additional factors, such as VPD coupling, site of origin, underlying subclinical pathology, and unidentified genetic factors, may be equally or even more important in the development of ventricular dysfunction. [5] [6] [7] [8] Using a cohort of patients with frequent VPDs, we previously demonstrated that patients with normal LV function, reversible LV dysfunction, and irreversible LV dysfunction exhibit a gradient of VPD QRS duration (QRSd). 9 The longest VPD QRSd was observed in the irreversible group, irrespective of the VPD site of origin. These findings are supported by other cross-sectional studies that have associated VPD QRSd with the presence of LV dysfunction in the context of frequent VPDs.
We hypothesized that the VPD QRSd reflects the degree of myofibril disarray and fibrosis of the underlying myocardium, which are the dominant pathologic findings in idiopathic LV CMP. 10, 11 The ability of VPD QRSd to discriminate patients with normal LV function from patients with impaired LV function is limited by the significant overlap between patients with normal LV function and those with reversible LV dysfunction. Paced QRSd from a standard reference pacing site may have significant advantages over VPD QRSd in differentiating patients with normal versus impaired LV function and frequent VPDs, since this technique eliminates the variability that is associated with different sites of origin. The purpose of this study was to determine whether, among patients with frequent VPDs, right ventricular apical (RVa)-paced QRSd can sufficiently discriminate patients with normal LV function from patients with impaired LV function.
METHODS

Study population
All patients with frequent VPDs (>1% burden or >1000 VPDs/24 h) who underwent successful radiofrequency (RF) catheter ablation 
ECG measurements
The RVa-paced QRSd was measured from the pacing stimulus to the latest QRS recording at any electrocardiography (ECG) lead (V 1 , V 6 
Statistical analysis
Differences in baseline characteristics between the groups of interest were carried out first in a univariate fashion using Fisher's exact t-test for categorical variables and the Kruskal-Wallis test for continuous variables. To determine independent predictors of LV dysfunction, multivariate analyses were performed using logistic regression.
All covariates were initially assessed in a univariate fashion and variables were introduced into the multivariate model if their likelihood ratio test P value was ≥0.20. All variables from the univariate analysis were added in a stepwise fashion, and interaction variables were also introduced to identify confounders and effect modifiers. The influence of each included variables on the model was assessed using a likelihood ratio test. For all continuous variables, the linear assumption was tested by plotting coefficients versus quartiles, as well as generating a lowess smoothed plot of the continuous variable against the logit of the dependent variable. Goodness of fit was assessed by calculating the area under the curve of the receiver operating table and using the Hosmer-Lemeshow test. All analyses were performed using SPSS Version 18.0 for Windows (IBM Corp., Armonk, NY, USA).
Ethics
The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki, and the research protocol was approved by the ethics committee of the University of Sungkyunkwan Health System. All patients provided written informed consent.
RESULTS
A total of 108 patients were enrolled in the retrospective study population from 2010 to 2016. Thirty-one patients were excluded due to episodes of sustained VT (n = 11) or secondary causes of LV dysfunction (n = 20; 12 with myocardial infarction, three with arrhythmogenic
TA B L E 1 Baseline epidemiologic and clinical characteristics of patients in the retrospective study
Variables
Normal LV function (n = 47) Impaired LV function (n = 15) P Value
Demographic variables
Male sex, n (%) 22 ( Receiver-operating characteristic (ROC) curve analysis showed that the RVa-paced QRSd in lead V6 was the best site for differentiating patients with impaired LV function from patients with normal LV function (94% sensitivity, 85% specificity, area under ROC curve = 0.94,
RVa-paced QRSd exhibited a strong negative correlation with LVEF ( 97% specificity) was a better predictor of CMP than daily VPD burden (cut-off value of 24%; 60% sensitivity, 64% specificity) ( Figure 2C ). The best cut-off for discriminating normal from impaired LV function using RVa-paced QRSd was 170.1 ms (73% sensitivity, 97% specificity); the area under the ROC curve was 0.94 in this case. In contrast, VPD QRSd was not as robust a discriminator. The best cut-off for VPD QRSd was 156.5 ms (sensitivity 71%, specificity 87%); this cut-off only yielded an area under the ROC curve of 0.84 ( Figure 3 ).
Multivariate analysis after adjusting for sex, LV end-diastolic dimension (LVEDD), and VPD burden revealed that only RVa-paced QRSd and spontaneous VPD QRSd were independently associated with the presence of LV dysfunction ( Table 3 
Intra-and inter-rater reliability of TTE measurements
The intra-and inter-rater correlation coefficients for VPD QRSd were 
DISCUSSION
In this study, RVa-paced QRSd accurately discriminated normal from impaired LV function among patients with frequent VPDs. An RVapaced QRSd value ≥170 ms was highly specific (97%) for the presence of impaired LV function in the validation cohort. Furthermore, RVa-paced QRSd was a better discriminator than either VPD QRSd or VPD burden, both of which have been associated with LV function in prior studies. Thus, QRSd measurements made during pacing from a standard site may overcome the limitations of VPD QRSd, whose values can vary highly depending on the VPD site of origin.
We hypothesized that an increased paced QRSd indicates underlying microscopic myocardial fiber disarray. Such diffuse myocardial changes may go undetected by contemporary imaging techniques but are readily manifested on ECGs.
Several investigators have studied the potential of factors gleaned from endomyocardial biopsy or autopsy to explain ventricular arrhythmias in this context. Lemery et al 6 described the clinical, laboratory, and electrophysiological features of "idiopathic" VT and reported that minor structural cardiac abnormalities were found in more than 30% of all patients. Roberts et al 10 found interstitial fibrosis, cellular hypertrophy, and degenerative changes in the pathologic biopsies
TA B L E 2 Comparison of ECG parameters among the three groups
Normal control (n = 50) Normal LV function (n = 47) Impaired LV function (n = 15) from patients with idiopathic CMP. Several studies in animal models have also described various microscopic pathologic findings after chronic ventricular pacing. 12, 13 However, recent imaging studies have not found any significantly abnormal findings in patients with nonischemic CMP that would corroborate the evidence of occult structural heart disease. 14 One possible explanation for these findings is that current imaging technologies might not be sensitive enough to identify occult structural abnormalities that may predispose patients to manifest CMP when their systems are stressed. Niwano et al 15 reported that patients with frequent VPDs and no structural heart disease had a benign prognosis over a 5.8-year prospective observation period. However, a considerable decrease in the LVEF was observed in some patients with frequent VPDs during the follow-up.
Thus, the authors hypothesized that occult structural heart disease may have existed in the CMP group at the baseline. Recently, two articles studying the effect of VPD QRSd on the development of CMP concluded that broader VPDs are associated with the development of VPD-induced CMP, independent of the VPD burden. 9, 16, 17 However, despite all these studies, the exact mechanism(s) underlying VPDinduced CMP are still unknown. Furthermore, additional confounding factors that could have influenced the ECG measurements, such as the body surface area/body mass index, LV dimension, and VPD site of origin, must also be taken into account. 18 In our study, there are higher proportion of male in impaired LV function group (86%) compared with normal group (46%). However, these results are consistent with our previous study and other studies results that the patients with VPD with LV dysfunction group had a higher male frequency than normal patients. 9, 18 To the best of our knowledge, this is the first study to show that arrhythmia-induced CMP can be predicted or diagnosed in its early stages by using simple RVa pacing during an EP study. In our study of patients with a long QRSd, we found that: (1) more effort is needed to characterize the arrhythmogenic substrate, and (2) more attention is needed to characterize the arrhythmia burden and the presence of underlying cryptogenic microscopic myocardial disease. The presence of a conduction delay suggests that fiber disarray may be present, predisposing the patient to CMP. Future studies will focus on determining that can "VPD stress test" be used not only to induce arrhythmias, but also to identify patients with progressive degrees of microscopic fibrosis that will ultimately lead to irreversible CMP. The ability of our assessment as a predictive tool for reversible or irreversible VPDinduced CMP also warrants future prospective evaluation. Moreover, additional long-term prospective studies are needed to thoroughly test the conclusions from the present study.
Limitations
Our study did have several limitations. First, this study was a singlecenter, small-numbers-of-patients study derived from a real-world practice with inherent limitations. Hence, the results of our study should be considered as hypothesis generating, and future prospective studies are warranted to confirm our results. Second, many patients were referred from other hospitals for ablation. Third, the age of patients (55 years) is relatively young in our study. Consequently, the enrolled patients may not be representative of all patients with frequent VPDs. To minimize this potential bias, we made every effort to enroll all patients with frequent VPDs who met the inclusion criteria, including patients with a daily VPD burden of over 1% or 1000.
Fourth, we used RVa pacing to measure the QRSd as a reflection of the transmyocardial conduction time. However, several confounding variables are likely to impact the conduction time. To reduce the effects of these variables, strict criteria were used to achieve adequate RVa pacing.
CONCLUSION
RVa pacing along with assessment of the transmyocardial conduction time was a useful method for identifying idiopathic VPD-induced CMP among patients with a similar body mass index, body surface area, daily VPD burden, and LVEDD. Using a QRSd cut-off value of 170.1 ms, VPDinduced CMP was identified with a sensitivity of 73% and a specificity of 97%.
